Does Wellcare Cover Trelegy?
The verdict
Covered on most plans
Wellcare (Centene) covers Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) on its Medicare Part D and Medicaid managed-care plans per the plan drug list. Trelegy is brand-only with no generic, so the coverage variable is prior authorization or step therapy rather than generic substitution. Medicaid enrollees face nominal cost-share on covered maintenance inhalers. The 2026 $2,100 Part D out-of-pocket cap applies to Medicare enrollees.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Wellcare using your member ID.
Key facts
Wellcare is a Centene-operated Part D and Medicaid managed-care plan with a readership skewing toward elderly, low-income, and dual-eligible beneficiaries.
CMS Medicare Part D enrollment data; Centene/Wellcare public filings
Trelegy Ellipta is brand-only — no FDA-approved generic exists as of 2026 — so step therapy rather than generic substitution is the coverage variable on Wellcare.
FDA drug labeling, Trelegy Ellipta
The 2026 Medicare Part D $2,100 beneficiary OOP cap limits annual out-of-pocket drug spending for all Part D enrollees including those on Wellcare plans.
CMS, Medicare Part D 2026 benefit parameters
Medicare vs. commercial coverage
Whether Wellcare covers Trelegy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Wellcare Medicare Part D plans operated by Centene cover Trelegy Ellipta as a covered brand maintenance inhaler for COPD and asthma. No generic exists, so there is no generic-substitution edit. Some Wellcare Part D plans apply prior authorization or step therapy requiring documentation of a simpler inhaler tried first. The 2026 Medicare Part D $2,100 out-of-pocket cap applies. Verify PA and step-therapy requirements on the Wellcare plan drug list or call Wellcare member services.
Commercial / Employer
Group & marketplace plans
Wellcare has a limited commercial and ACA/individual book; where offered, Trelegy is covered as a brand maintenance inhaler. Wellcare Medicaid managed-care plans (Centene-operated in multiple states) cover Trelegy per state PDL, with prior authorization and step therapy common for a brand-only triple-therapy inhaler. Medicaid enrollees pay nominal cost-share for covered maintenance medications. Verify coverage on the specific Wellcare plan drug list or state Medicaid PDL.
The 3 boxes you must tick to get approved
Commercial plans that will consider Trelegy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Trelegy actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$802–$918 per inhaler (30-day supply)
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D cost-share depends on plan tier; the 2026 $2,100 OOP cap limits annual exposure. Medicaid enrollees pay nominal cost-share per state Medicaid rules. Verify on the Wellcare plan drug list.
Typical monthly copay once prior authorization is approved.
Bridge program
GSK (Trelegy manufacturer) offers the myGSK Assistance Program for eligible uninsured and underinsured patients. Verify eligibility at gsk.com.
Reduced copay through the assistance program, where eligible.
All cost figures are estimates. No generic alternative exists for Trelegy. Actual cost-share depends on plan type (Part D vs Medicaid), tier, and deductible. Verify on the Wellcare plan drug list or call Wellcare member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check the Wellcare plan drug list
Go to wellcare.com and use the formulary or drug search tool. Enter 'Trelegy Ellipta,' select your specific Wellcare plan, and review tier, prior authorization status, and any step-therapy requirements.
- 2
Call Wellcare member services
Call the number on the back of your Wellcare member ID card and ask: Is Trelegy on my plan drug list? Is prior authorization or step therapy required? What is my expected cost-share per 30-day supply?
- 3
Ask your prescriber to initiate PA if required
If your Wellcare plan requires prior authorization or step-therapy documentation, your prescriber can submit clinical notes confirming COPD or asthma diagnosis and prior inhaler history to Wellcare's PA department.
Options if Wellcare won't cover Trelegy
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Anoro Ellipta (umeclidinium/vilanterol)
Dual-agent LABA/LAMA without an ICS; may be on a lower tier on Wellcare Part D or Medicaid plans where a dual agent is clinically appropriate as a step-therapy option.
Generic budesonide-formoterol (ICS/LABA)
Generic dual-agent ICS/LABA combination; widely covered on Wellcare Part D and Medicaid at a preferred tier — commonly the step-therapy option for asthma and COPD before brand triple therapy is approved.
Breztri Aerosphere (budesonide/glycopyrrolate/formoterol)
Another brand triple-therapy COPD inhaler; compare tier placement with Trelegy on your Wellcare plan drug list to determine which is covered at the lower cost.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Wellcare Medicare Part D plans (Centene-operated) cover Trelegy Ellipta per the plan drug list as a brand maintenance inhaler for COPD and asthma. No generic exists, so there is no generic-substitution question. Some Wellcare plans apply prior authorization or step therapy. The 2026 $2,100 Part D OOP cap limits annual cost exposure. Verify on your specific Wellcare plan drug list or call member services to confirm PA requirements and your exact cost-share.
Wellcare Medicaid managed-care plans (Centene) generally cover Trelegy Ellipta per the applicable state PDL, subject to prior authorization and step therapy that are common for brand-only triple-therapy inhalers in Medicaid programs. Medicaid enrollees pay nominal cost-share on covered maintenance medications. Coverage and PA requirements vary by state Medicaid rules. Verify on your state's Medicaid PDL or the Wellcare Medicaid plan drug list for your state.
No. Trelegy Ellipta is brand-only — no FDA-approved generic exists as of 2026. Unlike Symbicort, where Wellcare can steer patients to a lower-cost generic (budesonide/formoterol), there is no generic Trelegy. The coverage pathway for Trelegy on Wellcare plans is through meeting PA or step-therapy requirements on the brand, not switching to a generic.
Yes. The 2026 Medicare Part D $2,100 beneficiary out-of-pocket cap applies to all covered Part D drugs including Trelegy on Wellcare Medicare Part D plans. Once you reach the cap, you pay $0 for covered Part D drugs for the remainder of the year. This is the operative cost protection for Wellcare Medicare enrollees given Trelegy's $802–$918 cash price. Verify your plan's Trelegy tier to understand cost-share before hitting the cap.
Trelegy was selected by CMS for Medicare price negotiation in a later cohort — not the first 10 drugs whose negotiated prices took effect in 2026. No government-negotiated Trelegy price was in effect for Wellcare Medicare plans in 2026. Do not assume any negotiated-price savings in 2026. Verify the current effective year on the CMS selected-drug list before expecting a reduction beyond standard 2026 OOP cap protections.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Wellcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.